Just met with Stephen Hamilton and some of the new hires at Wheeler Bio’s recently finished Boston Lab.
Just met with Stephen Hamilton and some of the new hires at Wheeler Bio’s recently finished Boston Lab.
Wheeler Bio’s AMBR® 250 is ready to go! The high-throughput automated bioreactor system with 12 or 24 fully-featured single-use 100-250 mL mini bioreactors has a wide range of applications in process development and optimization, scale-down studies, and cell culture and microbial fermentation.
Wheeler Bio’s Stephen Hamilton and Michael Brem recently published an article about Wheeler’s ambitions to bring about a paradigm shift in biologics development via open-source manufacturing processes and parallel service integration. Check out their website for the full article.
Wheeler Bio, a cell line development and biologics CDMO, launched its new website, complete with a brand new look and feel. Check out www.wheelerbio.com to learn how Wheeler is advancing discovery to development for biopharma.
Construction of Wheeler’s Ziggurat campus is underway. The complex — scheduled to open in 2024 — will include a hotel, biotech office space, and a MAPS 4-funded Innovation Hall.
Jesse McCool, CEO of WheelerBio, and our own Jason Rahal sign the I-beam from Wheeler’s new cGMP facility.